|
|   |
Home (12954 companies) > Netherlands (195 companies) > Chemicals (9 companies) >
DSM NV
| Headquarters location: P.O. Box 6500 6410 JH Heerlen |  | Tel. 31455788111 Job offers, investor relations: www.dsm.nl Stock:  |
|
| shareholder | country  % source |
|
|
name  items photo compare the prices |
Shop local, ethical and at the best price on Ethishop ! |
|
|
« ETHICAL » RATING OF DSM
, group
and subsidiaries
[ ?] |
| Job: 12% of company's jobs cut since 1998 |
| Net profit: more than 4 billion(s) dollars/euros in cumulated net profit since 1998 |
| Influence: 5 act(s) of direct corruption or lobbying |
|
|
year name | photo position; compensation source |
|
|
year | employees <> | social impact : country source |
| 2005 | -350 | Closure/Bankruptcy: Closes down production of bulk vitamin C in the US and cuts costs at its plant in Dalry, Scotland: | Nutra-ingr.  |
| 2004 | -400 | Relocation: Will restructure its money-losing anti-infectives business, closing capacity in Europe and increasing output in Asia. 13% of the business's total will go. Weak markets, the decline of the dollar, and strong growth in Asia are cited as main reasons for the restructuring. A plant at Delft and a plant at Geleen, the Netherlands, will close in 2005. A joint venture with Glaxo SmithKline at Irvine, UK is to end in 2005. DSM is to expand and upgrade production at its anti-infectives plant at Toansa, India, and at its joint venture's at Harbin, Zhang Jiakou, and Zibo, China. The restructuring should mean annualized cost savings of tens of millions of euros within two years.: |  |
| 2004 | -39 | Internal restructuring: Edicom  | |
| 2003 | -200 | | AP  |
| 2002 | 18375 | |  |
| 2002 | -100 | | AP  |
| 2000 | | |  |
| 2000 | -1000 | | AP  |
|
year |   | sales | income | | | source |
| 2004 |
| 7.75 | 0.26 | |   | billion Eu€ |  |
| 2003 |
| 6.05 | 0.14 | |   | billion Eu€ |  |
| 2002 |
| 6.66 | 1.19 | |   | billion Eu€ |  |
| 2001 |
| 7.97 | 1.42 | |   | billion Eu€ |  |
| 2000 |
| 8.09 | 0.58 | |   | billion Eu€ |  |
| 1999 |
| 6.33 | 0.37 | |   | billion Eu€ |  |
|
|
|
|
Also announce a documentary, a book or an article or comment this company profile.
Goal: present the company activities, improve the ethical rating's accuracy, develop an network of observers.